Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation

被引:2
作者
Jiang, Yunzhong [1 ]
Zhang, Mengzhao [2 ]
Wang, Lu [1 ]
Zhang, Lu [1 ]
Ma, Minghai [1 ]
Jing, Minxuan [1 ]
Li, Jianpeng [1 ]
Song, Rundong [1 ]
Zhang, Yuanquan [1 ]
Yang, Zezhong [1 ]
Zhang, Yaodong [1 ]
Pu, Yuanchun [1 ]
Qu, Xiaowei [3 ]
Fan, Jinhai [1 ,4 ]
机构
[1] Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 1, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Vasc Surg, Affiliated Hosp 1, Xian, Peoples R China
[3] Yanan Univ, Dept Geriatr, Xianyang Hosp, Xianyang, Peoples R China
[4] Minist Educ, Key Lab Environm & Genes Related Dis, Oncol Res Lab, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
Osthole; Bladder cancer; Network Pharmacology; Molecular docking; CNIDIUM-MONNIERI; WEB SERVER; THYMOQUINONE; INHIBITION; UPDATE; GENES;
D O I
10.1186/s12906-023-03938-5
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
BackgroundOsthole was traditionally used in treatment for various diseases. However, few studies had demonstrated that osthole could suppress bladder cancer cells and its mechanism was unclear. Therefore, we performed a research to explore the potential mechanism for osthole against bladder cancer.MethodsInternet web servers SwissTargetPrediction, PharmMapper, SuperPRED, and TargetNet were used to predict the Osthole targets. GeneCards and the OMIM database were used to indicate bladder cancer targets. The intersection of two target gene fragments was used to obtain the key target genes. Protein-protein interaction (PPI) analysis was performed using the Search Tool for the Retrieval of Interacting Genes (STRING) database. Furthermore, we used gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses to explore the molecular function of target genes. AutoDock software was then used to perform molecular docking of target genes,osthole and co-crystal ligand. Finally, an in vitro experiment was conducted to validate bladder cancer inhibition by osthole.ResultsOur analysis identified 369 intersection genes for osthole, the top ten target genes included MAPK1, AKT1, SRC, HRAS, HASP90AA1, PIK3R1, PTPN11, MAPK14, CREBBP, and RXRA. The GO and KEGG pathway enrichment results revealed that the PI3K-AKT pathway was closely correlated with osthole against bladder cancer. The osthole had cytotoxic effect on bladder cancer cells according to the cytotoxic assay. Additionally, osthole blocked the bladder cancer epithelial-mesenchymal transition and promoted bladder cancer cell apoptosis by inhibiting the PI3K-AKT and Janus kinase/signal transducer and activator of transcription (JAK/STAT3) pathways.ConclusionsWe found that osthole had cytotoxic effect on bladder cancer cells and inhibited invasion, migration, and epithelial-mesenchymal transition by inhibiting PI3K-AKT and JAK/STAT3 pathways in in vitro experiment. Above all, osthole might have potential significance in treatment of bladder cancer.SubjectsBioinformatics, Computational Biology, Molecular Biology.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Unveiling esophageal cancer treatment mechanisms: network pharmacology and molecular docking of Physcion
    Hu, Guangbing
    Guo, Haiyang
    Lu, Liuyi
    Zhang, Zongyao
    Tang, Yong
    Zuo, Ji
    Wang, Xianfei
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025, 398 (01) : 557 - 568
  • [42] Potential Mechanism of Dingji Fumai Decoction Against Atrial Fibrillation Based on Network Pharmacology, Molecular Docking, and Experimental Verification Integration Strategy
    Liang, Yi
    Liang, Bo
    Chen, Wen
    Wu, Xin-Rui
    Liu-Huo, Wu-Sha
    Zhao, Li-Zhi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [43] Combined Network Pharmacology, Molecular Docking, and Experimental Verification Approach to Investigate the Potential Mechanisms of Polydatin Against COVID-19
    Wang, Meng
    Qin, Kaijian
    Zhai, Xiaofeng
    NATURAL PRODUCT COMMUNICATIONS, 2022, 17 (04)
  • [44] Network Pharmacology, Molecular Docking, and Experimental Validation on Guiluoshi Anzang Decoction Against Premature Ovarian Insufficiency
    Wu, Yuanyuan
    Long, Yunxia
    Su, Guangheng
    Fan, Xiangping
    He, Guozhen
    Luo, Zhijuan
    Luo, Songping
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2025, 28 (04) : 724 - 736
  • [45] Network pharmacology and molecular docking analysis on molecular targets: Mechanisms of baicalin and baicalein against hyperuricemic nephropathy
    Xiang, Huilong
    Lei, Huan
    Liu, Ziyuan
    Liu, Yongjie
    Li, Yang
    Qiu, Yinsheng
    Xu, Lingyun
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 424
  • [46] Molecular Mechanisms of Luteolin Against Atopic Dermatitis Based on Network Pharmacology and in vivo Experimental Validation
    Tang, Liu
    Gao, Jiefang
    Li, Xiaolei
    Cao, Xiaoqin
    Zhou, Benhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 4205 - 4221
  • [47] Investigation of the mechanism of baicalein in the treatment of periodontitis based on network pharmacology, molecular docking and experimental validation
    Liu, Yue
    Cao, Fengdi
    Shi, Mingyue
    Deng, Zhuohang
    Guo, Kaili
    Fan, Tiantian
    Meng, Yuhan
    Bu, Mingyang
    Ma, Zhe
    BMC ORAL HEALTH, 2024, 24 (01):
  • [48] Integrated network pharmacology, bioinformatics, and molecular docking to explore the mechanisms of berberine regulating autophagy in breast cancer
    Huang, Bowan
    Wen, Gengzhi
    Li, Rujia
    Wu, Minhua
    Zou, Zhenning
    MEDICINE, 2023, 102 (36) : E35070
  • [49] Exploration of Dan-Shen-Yin against pancreatic cancer based on network pharmacology combined with molecular docking and experimental validation
    Gu, Ao
    Li, Jiatong
    Wu, Jian-An
    Li, Meng-Yao
    Liu, Yingbin
    CURRENT RESEARCH IN BIOTECHNOLOGY, 2024, 7
  • [50] Exploring the mechanism and experimental validation of Fuzi Lizhong Tang in treating gastric cancer based on network pharmacology and molecular docking
    Zhang, F. -Y.
    Guo, S. -C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (19) : 9192 - 9204